Compare Elder Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC PHARMA ELDER PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x -0.2 17.4 - View Chart
P/BV x 0.1 6.9 1.5% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC PHARMA
Mar-19
ELDER PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs380664 57.2%   
Low Rs188412 45.6%   
Sales per share (Unadj.) Rs491.2208.7 235.3%  
Earnings per share (Unadj.) Rs-3.231.0 -10.3%  
Cash flow per share (Unadj.) Rs14.437.1 38.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs376.5144.2 261.1%  
Shares outstanding (eoy) m20.54188.52 10.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.6 22.4%   
Avg P/E ratio x-89.317.4 -514.1%  
P/CF ratio (eoy) x19.714.5 135.9%  
Price / Book Value ratio x0.83.7 20.2%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m5,833101,461 5.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1797,467 29.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,08939,347 25.6%  
Other income Rs m25794 273.6%   
Total revenues Rs m10,34639,441 26.2%   
Gross profit Rs m-7928,736 -9.1%  
Depreciation Rs m3611,152 31.4%   
Interest Rs m2,756184 1,497.2%   
Profit before tax Rs m-3,6537,493 -48.7%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,568 8.0%   
Profit after tax Rs m-655,844 -1.1%  
Gross profit margin %-7.822.2 -35.4%  
Effective tax rate %-3.420.9 -16.4%   
Net profit margin %-0.614.9 -4.4%  
BALANCE SHEET DATA
Current assets Rs m9,24019,577 47.2%   
Current liabilities Rs m9,99814,896 67.1%   
Net working cap to sales %-7.511.9 -63.1%  
Current ratio x0.91.3 70.3%  
Inventory Days Days4690 51.6%  
Debtors Days Days6045 132.2%  
Net fixed assets Rs m10,12427,097 37.4%   
Share capital Rs m206377 54.6%   
"Free" reserves Rs m5,58226,811 20.8%   
Net worth Rs m7,73427,188 28.4%   
Long term debt Rs m4,8894,993 97.9%   
Total assets Rs m22,88247,778 47.9%  
Interest coverage x-0.341.7 -0.8%   
Debt to equity ratio x0.60.2 344.2%  
Sales to assets ratio x0.40.8 53.5%   
Return on assets %11.812.6 93.2%  
Return on equity %-0.821.5 -3.9%  
Return on capital %22.323.6 94.5%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30719,453 1.6%   
Fx outflow Rs m1256,065 2.1%   
Net fx Rs m18113,388 1.4%   
CASH FLOW
From Operations Rs m11,7548,120 144.8%  
From Investments Rs m-561-7,556 7.4%  
From Financial Activity Rs m-6,762590 -1,145.3%  
Net Cashflow Rs m4,4321,153 384.3%  

Share Holding

Indian Promoters % 39.6 74.1 53.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 2.9 258.6%  
FIIs % 16.8 9.1 184.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 13.9 259.7%  
Shareholders   16,479 49,328 33.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   NEULAND LABS  DR. REDDYS LAB  NOVARTIS  ALEMBIC  PROCTER & GAMBLE HEALTH  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Behind the Stock Market Crash, HDFC Bank Q4FY21 Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets nosedived and registered sharp losses in yesterday's volatile session following a strong second wave of Covid-19 in the country.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS